0 items USD 0.00Search
Your search for "chronic hepatitis C" gave back 8892 results.
The global Anti-Hepatitis C Drugs market size was valued at US$ 2263.7 million in 2022. With growing demand in downstream market, the Anti-Hepatitis...
Catalog:
LPI
December 2023
Price: USD 3,660.00
It means a treatment of Hepatitis B—— contagious liver infection that can be long lasting. The global Hepatitis B Treatment market was valued at US$...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Human Hepatitis B Immunoglobulin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Treatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medications — including entecavir (Baraclude), tenofovir (...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Treatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medications — including entecavir (Baraclude), tenofovir (...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Recombinant human interferon α1b for injection is suitable for the treatment of viral diseases and certain malignant tumors. It has been approved for...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
It means a treatment of Hepatitis B—— contagious liver infection that can be long lasting. The “Hepatitis B Treatment Industry Forecast” looks at...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Prophylactic Hepatitis B Virus Vaccines market size was valued at US$ million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
March 2024
Price: USD 3,660.00
